---
title: "The manufacturer of the \"miracle weight-loss drug,\" Nuohe Nordic, has raised its full-year operating profit guidance to an increase of 40%-46%."
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/99868702.md"
description: "Novo Nordisk has raised its full-year operating profit (at constant exchange rates) guidance to a growth of 40%-46%, higher than analysts' expectations of 37.5%. The company had originally forecasted..."
datetime: "2023-10-13T13:49:56.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/99868702.md)
  - [en](https://longbridge.com/en/news/99868702.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/99868702.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/99868702.md) | [繁體中文](https://longbridge.com/zh-HK/news/99868702.md)


# The manufacturer of the "miracle weight-loss drug," Nuohe Nordic, has raised its full-year operating profit guidance to an increase of 40%-46%.

Novo Nordisk has raised its full-year operating profit (at constant exchange rates) guidance to a growth of 40%-46%, higher than analysts' expected growth of 37.5%. The company's original forecast was a growth of 31%-37%. Novo Nordisk's stock price in Copenhagen (NOVOB.DC) is currently down 2.35%, deviating from the historical high set on October 12. Novo Nordisk's ADR (NVO) in the US pre-market is up 1.56%. Eli Lilly's stock in the US pre-market is up nearly 1%.

### Related Stocks

- [Novo Nordisk A/S (NVO.US)](https://longbridge.com/en/quote/NVO.US.md)

## Related News & Research

- [Novo Nordisk A/S $NVO Shares Purchased by Heirloom Wealth Management](https://longbridge.com/en/news/281345767.md)
- [British drug-cost watchdog recommends use of Novo's Wegovy to lower heart risks](https://longbridge.com/en/news/281263193.md)
- [5 Simple ETFs to Buy With $1,000 and Hold for a Lifetime](https://longbridge.com/en/news/281345615.md)
- [BUZZ-Rosenblatt says finding partner for Snap's smart glasses unit tough](https://longbridge.com/en/news/281357569.md)
- [BUZZ-Street View: Nike's turnaround remains work in progress](https://longbridge.com/en/news/281331333.md)